XML 8 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Investments, at fair value    
Investments, at fair value $ 1,591,433 $ 1,582,075
Cash and cash equivalents 17,086 7,780
Restricted cash and cash equivalents 20,751 16,690
Interest and dividend receivable 10,640 14,000
Receivable from unsettled transactions 131 251
Unrealized appreciation on foreign currency forward contracts 1,396 5,128
Deferred tax assets 503 114
Other assets 3,109 1,341
Total assets 1,645,049 1,627,379
Liabilities    
Debt (net of deferred financing costs of $7,358 and $7,138, respectively) 857,236 844,783
Distributions payable 15,566 15,195
Interest and other debt financing costs payable 9,116 10,900
Management fees payable 5,089 5,026
Incentive fees payable 4,899 4,770
Deferred tax liabilities 503 578
Unrealized depreciation on foreign currency forward contracts 77 84
Accrued expenses and other liabilities 3,756 3,449
Total liabilities 896,242 884,785
Commitments and Contingencies (Note 8)
Net assets    
Common stock, par value $0.001 per share (200,000,000 shares authorized, 37,061,547 shares issued and outstanding) 37 37
Paid-in capital in excess of par value 965,895 965,895
Accumulated earnings (loss) (217,125) (223,338)
Total net assets 748,807 742,594
Total liabilities and net assets $ 1,645,049 $ 1,627,379
Net asset value per share $ 20.2 $ 20.04
Non-controlled non-affiliated    
Investments, at fair value    
Investments, at fair value $ 1,492,347 $ 1,465,537
Non-controlled affiliated    
Investments, at fair value    
Investments, at fair value 51,003 52,619
Controlled    
Investments, at fair value    
Investments, at fair value $ 48,083 $ 63,919